| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Incorporated (LGNZZ) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 3 sells.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 199.4K | $16.0K | - | |
| Other | 41.4K | $3.3K | - | |
| Dir | 32.8K | $2.6K | - | |
| CFO | 21.0K | $1.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Sabba Stephen L | Director | Sell | 1,000 | $207.87 | $207,872.70 | -3.0% | |
| Mar 11, 2026 | Espinoza Octavio45 | Chief Financial Officer | Sale+OE | 3,057 | $225.00 | $687,825.00 | -12.7% | |
| Mar 3, 2026 | Sabba Stephen L | Director | Sale+OE | 2,034 | $201.50 | $409,851.00 | -5.7% |